6 recruiting. 6 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Recruiting 6 |
| Phase 1 | 1 | Recruiting 1 |
Follow Hemangiosarcoma: new trials by email Literature Review of Hemangiosarcoma trials Research Report on Hemangiosarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intratumoral Vusolimogene Oderparepvec (VO) in Combination With Pembrolizumab for Angiosarcoma Vusolimogene Oderparepvec (VO), Pembrolizumab - Angiosarcoma, Angiosarcoma, Adult | Phase 2 | Recruiting | Varun Monga, MBBS | 18 | 2026-01-09 | 2026-09-01 |
| IO Combined With AI as First-line Treatment for Patients With Soft Tissue Sarcoma(TAIS) Tislelizumab+liposomal doxorubicin+ifosfamide - Soft Tissue Sarcomas, Angiosarcoma | Phase 2 | Recruiting | Fudan University | 45 | 2025-02-25 | 2026-01-08 |
| NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) Surgical resection, Proton beam radiation therapy, Pazopanib - Adipocytic Neoplasm, Liposarcoma | Phase 1 / Phase 2 | Recruiting | St. Jude Children's Research Hospital | 139 | 2024-03-27 | 2026-08-03 |
| MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma MASCT-I, Doxorubicin, Ifosfamide - Leiomyosarcoma, Liposarcoma | Phase 2 | Recruiting | HRYZ Biotech Co. | 148 | 2024-02-21 | 2025-07-24 |
| Propranolol and Pembrolizumab in Advanced Soft Tissue Sarcoma Patients Propranolol, Pembrolizumab - Soft Tissue Sarcoma Adult, Angiosarcoma | Phase 2 | Recruiting | Niels Junker | 80 | 2021-08-17 | 2023-07-27 |
| I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer Standard Therapy, AMG 386 with or without Trastuzumab, AMG 479 (Ganitumab) plus Metformin - Breast Neoplasms, Breast Cancer | Phase 2 | Recruiting | QuantumLeap Healthcare Collaborative | 5000 | 2010-03-01 | 2026-05-06 |
Sarcoma (4) · Fibrosarcoma (3) · Leiomyosarcoma (3) · Liposarcoma (3) · Neurofibrosarcoma (3) · Desmoplastic Small Round Cell Tumor (2) · Histiocytoma, Malignant Fibrous (2) · Sarcoma, Synovial (2) · Breast Neoplasms (1) · Chondrosarcoma, Extraskeletal Myxoid (1) · Dermatofibrosarcoma (1) · Disorders of Sex Development (1) · Glomus Tumor (1) · Granular Cell Tumor (1)
Neoplasms by Histologic Type (6) · Neoplasms, Connective and Soft Tissue (6) · Neoplasms, Vascular Tissue (6) · Neoplasms (5) · Neoplasms, Connective Tissue (4) · Neoplasms, Fibrous Tissue (4) · Neoplasms, Muscle Tissue (3) · Neoplasms, Nerve Tissue (3) · Nervous System Diseases (3) · Nervous System Neoplasms (3) · Neurofibroma (3) · Neuromuscular Diseases (3) · Peripheral Nervous System Diseases (3) · Peripheral Nervous System Neoplasms (3) · Female Urogenital Diseases (2)
Doxorubicin (3) · pembrolizumab (3) · Ifosfamide (2) · 4-hydroxy-N-desmethyltamoxifen (1) · ARX788 (1) · Ado-Trastuzumab Emtansine (1) · Carboplatin (1) · Injections (1) · Irinotecan (1) · Lasofoxifene (1) · Letrozole (1) · MK 2206 (1) · Paclitaxel (1) · Propranolol (1) · Proton Therapy (1)
Fudan University (1) · HRYZ Biotech Co. (1) · Niels Junker (1) · QuantumLeap Healthcare Collaborative (1) · St. Jude Children's Research Hospital (1) · Varun Monga, MBBS (1)
United States (3) · China (2) · Denmark (1) · Norway (1) · Sweden (1)
Jessica Gartrell, MD (1) · Laura Esserman, MD, MBA (1) · Niels Junker, MD, PhD (1) · Varun Monga, MBBS (1) · Xing Zhang (1) · Zhang Xing (1)
PMID 21796368, PMID 22198468, PMID 22623692, PMID 22649152, PMID 27406346, PMID 27406347, PMID 28851423, PMID 32031889, PMID 32053137, PMID 32450725, PMID 32701140, PMID 34529000, PMID 34741021, PMID 35623341, PMID 35993306, PMID 36069821, PMID 36456573, PMID 37029329, PMID 37325931, PMID 37505107, PMID 38086377, PMID 38180338, PMID 38745646, PMID 39158353, PMID 39277671, PMID 39277672, PMID 39613746, PMID 39625569, PMID 40526879, PMID 40551254, PMID 40639409, PMID 40679371, PMID 40777112, PMID 41879562, PMID 42530945, PMID 42545411, PMID 42619946, PMID 42811224